With hopes that Covid is in retreat and that inflation will moderate in the year ahead, we take a last look at who had it good and who had it bad in 2022.
The book is ranked No. 22 on Amazon's list of best-selling economic history books, yet it's filled with factual errors.
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual...
Shares of Starbucks have risen 7% over the past year, bringing its market cap up to $113.4 billion.
Boeing's Air Force one plane has been overbudget and delayed.
Robert F. Kennedy Jr., if confirmed as HHS secretary, could help food-as-medicine startups expand with wider government health plan coverage.
Visa will enable X users to move funds between traditional bank accounts and their digital wallet and make instant peer-to-peer...